Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.04. | (BACK) - Analyzing IMAC Holdings' Short Interest | 2 | Benzinga.com | ||
19.04. | Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers | 3 | Seeking Alpha | ||
17.04. | IMAC Holdings Inc reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
16.04. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
16.04. | IMAC Holdings, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
01.04. | IMAC Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 2 | SEC Filings | ||
23.02. | IMAC Holdings, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
13.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 4 | 4.356 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS42328V8019 HELIUS... ► Artikel lesen | |
11.01. | IMAC Holdings, Inc. - S-4/A, Registration of securities, business combinations | 1 | SEC Filings | ||
27.12.23 | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
26.12.23 | Inspira, Journey Medical, IMAC Holdings among healthcare movers | 4 | Seeking Alpha | ||
24.11.23 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
22.11.23 | IMAC Holdings Inc reports results for the quarter ended in September - Earnings Summary | 1 | Reuters | ||
21.11.23 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
13.11.23 | Theralink Technologies, Inc.: Theralink and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4 | 137 | GlobeNewswire (Europe) | Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink"), a precision oncology company with its exclusive commercial RPPA (reverse... ► Artikel lesen | |
09.11.23 | IMAC Holdings, Inc. - S-4/A, Registration of securities, business combinations | 2 | SEC Filings | ||
04.10.23 | Theralink Technologies, Inc.: Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023 | 416 | GlobeNewswire (Europe) | Golden, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay... ► Artikel lesen | |
27.09.23 | IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements | 283 | GlobeNewswire (Europe) | Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC" or the "Company") today announced that it has received notice from The Nasdaq Stock Market LLC informing... ► Artikel lesen | |
11.09.23 | XFRA I020: AUSSETZUNG/SUSPENSION | 351 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIMAC HLDGS NEW DL-... ► Artikel lesen | |
11.09.23 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 11.09.2023 | 605 | Xetra Newsboard | The following instruments on XETRA do have their first trading 11.09.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.09.2023
Aktien
1 AU0000010522 Macquarie Group Ltd.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 1,532 | +3,93 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
ASENSUS SURGICAL | 0,238 | +1,71 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,320 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve changes auditor to MS Partners | ||
REWALK ROBOTICS | 4,675 | 0,00 % | Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings? | ||
VOLITIONRX | 0,918 | +3,16 % | VOLITIONRX LTD - 8-K, Current Report | ||
EKSO BIONICS | 1,170 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 | ||
BIOCEPT | 6,800 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 02.11.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.11.2023ISIN NameCA91834N1006 VSBLTY... ► Artikel lesen | |
IMUNON | 1,250 | -7,41 % | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen | |
AVINGER | 2,750 | -100,00 % | Avinger, Inc.: Avinger Reports Fourth Quarter and Full Year 2023 Results | New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in AsiaREDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger... ► Artikel lesen | |
ROCKWELL MEDICAL | 1,390 | +1,61 % | Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 | WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis... ► Artikel lesen | |
SINTX TECHNOLOGIES | 0,038 | +0,26 % | SINTX Technologies, Inc.: SINTX Technologies Announces Proposed Public Offering of Common Stock | SALT LAKE CITY, UT, March 29, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, today announced... ► Artikel lesen | |
INSPIREMD | 1,770 | +4,12 % | InspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update | - Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 - - Announced positive 30-day data from the Company's ongoing U.S. Investigational Device... ► Artikel lesen | |
VIRIDIAN THERAPEUTICS | 11,700 | -2,50 % | Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results | WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare... ► Artikel lesen |